author-photo

Philippe Moris

GlaxoSmithKline

54

Papers

3204

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study.

2020 American Journal of Tropical Medicine and Hygiene
Show All
- Source
- Cite
- Save
Citations (3)
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

2019 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (7)
First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.

2019 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (6)
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine

2018 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (24)
A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.

2016 Medicine
Show All
- Source
- Cite
- Save
Citations (20)
Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study.

2016 Tuberculosis
Show All
- Source
- Cite
- Save
Citations (41)
Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (45)
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (70)
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (62)
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (13)